Patents Represented by Attorney Astrazeneca Pharmaceuticals
  • Patent number: 6963011
    Abstract: A compound of the formula: wherein R1, R2, R3, R4, R5, R6, X1 and X2 are as defined in the specification useful for the treatment of diseases in which action of the neurokinin 1 receptor is implicated, methods of using such compounds and pharmaceutical compositions comprising such compounds.
    Type: Grant
    Filed: July 31, 2001
    Date of Patent: November 8, 2005
    Assignee: Astrazeneca AB
    Inventor: Peter Bernstein